Evidence map›Paper›PMID 35157774›Full record

ArticleGlycobiology2022

Meeting report on 14th Jenner Glycobiology and Medicine Symposium: glycobiology in immunology, medicine, and clinical practice.

Roisin O'Flaherty, Ghislain Opdenakker, Henrik Clausen, Rita Gerardy-Schahn, Claudine Kieda, Celso A Reis, Pauline M Rudd, Azita Sadrieh, John Axford

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Glycobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roisin O'FlahertyDepartment of Chemistry, Maynooth University, Maynooth, Co. Kildare, W23 F2H6, Ireland.ORCID 0000-0003-1941-4775
Ghislain OpdenakkerRega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Herestraat 49, Leuven, KU Leuven, BE-3000, Belgium.ORCID 0000-0003-1714-2294
Henrik ClausenCopenhagen Centre for Glycomics, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark.
Rita Gerardy-SchahnInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, 30625, Hannover, Germany.
Claudine KiedaCentre for Molecular Biophysics, Cell Recognition and Glycobiology, UPR4301-CNRS, rue Charles Sadron, 45071, Orléans, France.
Celso A ReisGlycobiology in Cancer, i3S - Institute for Research and Innovation in Health, University of Porto, 4200-135, Porto, Portugal.ORCID 0000-0002-0286-6639
Pauline M RuddUCD School of Medicine, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
Azita SadriehDepartment of Clinical Rheumatology, St. George's University of London, London, SW17 0QT, UK.
John AxfordDepartment of Clinical Rheumatology, St. George's University of London, London, SW17 0QT, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35157774
PMCPMC9132246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.